Welcome to the United Nations 
Infographic to the 2025 Coordination Segment
68th session (10 – 14 March 2025), Vienna.
Report of the Commission on Narcotic Drugs on its sixty-eighth session [E/2025/28]
Resolutions/decisions adopted by the Council at the 2025 Management Segment as recommended by the Commission on its 68th session [E/2025/28, chap. I, sect. A] 
20(d) 
10 June 2025
Draft decision I: Report of the Commission on Narcotic Drugs on its sixty-eighth session and provisional agenda for its sixty-ninth session
Draft decision II: Report of the International Narcotics Control Board
Further resolutions/decisions adopted by the CND on its 68th session [E/2025/28, chap. I, sect. B]:
Resolution 68/1: Promoting comprehensive, scientific evidence-based and multisectoral national systems of drug use prevention for children and adolescents
Resolution 68/2: Promoting research on scientific evidence-based interventions for the treatment and care of stimulant use disorders
Resolution 68/3: Complementing the United Nations Guiding Principles on Alternative Development
Resolution 68/4: Safety of officers in dismantling illicit synthetic drug laboratories, in particular those involving synthetic opioids
Resolution 68/5: Addressing the impacts of illicit drug-related activities on the environment
Resolution 68/6: Strengthening the international drug control system: a path to effective implementation
Decision 68/1: Inclusion of N-pyrrolidino protonitazene in Schedule I of the Single Convention on Narcotic Drugs of 1961 as amended by the 1972 Protocol
Decision 68/2: Inclusion N-pyrrolidino metonitazene in Schedule I of the Single Convention on Narcotic Drugs of 1961 as amended by the 1972 Protocol
Decision 68/3: Inclusion of etonitazepipne in Schedule I of the Single Convention on Narcotic Drugs of 1961 as amended by the 1972 Protocol
Decision 68/4: Inclusion of N-desethyl isotonitazene in Schedule I of the Single Convention on Narcotic Drugs of 1961 as amended by the 1972 Protocol
Decision 68/5: Inclusion of hexahydrocannabinol in Schedule II of the Convention on Psychotropic Substances of 1971
Decision 68/6: Inclusion of carisoprodol in Schedule IV of the Convention on Psychotropic Substances of 1971
Decision 68/7: Decision to move 3,4-MDP-2-P methyl glycidate (“PMK glycidate”) from the body of Table I of the United Nations
Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988 Convention to footnote 1 to that table, as the “methyl ester”
Reconvened 67th session (5–6 December 2024), Vienna.
Report of the Commission on Narcotic Drugs on its reconvened sixty-seventh session [E/2025/28/Add.1]
Resolutions/decisions adopted by the Council at the 2025 Management Segment as recommended by the Commission on its reconvened 67th session [E/2025/28/Add.1, chap. I, sect. A] 20(d) 10 June 2025
Draft decision: Report of the Commission on Narcotic Drugs on its reconvened sixty-seventh session
Further resolutions/decisions adopted by the CND on its reconvened 67th session [E/2025/28/Add.1, chap. I, sect. B]:
Resolution 67/5: Implementation of the budget for the biennium 2024–2025 for the Fund of the United Nations International Drug Control Programme
Decision 67/26: Participation of the European Union in the work of the Commission
Further resources: